Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Raimondo

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signalingA Romano, N L Parrinello, V Simeon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana LinfomiS Luminari, I Biasoli, L Arcaini, et al.
Blood Cancer Journal|September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomeD Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Leukemia|September 23, 2017
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathwaysD Benedetti, E Tissino, F Pozzo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre studyA Andriani, A Zullo, F Di Raimondo, et al.
Leukemia|April 26, 2016
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaM Dal Bo, P Bulian, R Bomben, et al.
Cell Death & Disease|October 18, 2023
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromesC Giallongo, I Dulcamare, S Giallongo, et al.
Leukemia|October 3, 2002
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemiaM Mancini, M L Vegna, G L Castoldi, et al.
Bone Marrow Transplantation|January 21, 2014
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosisM Magni, M Di Nicola, C Patti, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signalingA Romano, N L Parrinello, V Simeon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana LinfomiS Luminari, I Biasoli, L Arcaini, et al.
Blood Cancer Journal|September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomeD Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Leukemia|September 23, 2017
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathwaysD Benedetti, E Tissino, F Pozzo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre studyA Andriani, A Zullo, F Di Raimondo, et al.
Leukemia|April 26, 2016
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaM Dal Bo, P Bulian, R Bomben, et al.
Cell Death & Disease|October 18, 2023
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromesC Giallongo, I Dulcamare, S Giallongo, et al.
Leukemia|October 3, 2002
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemiaM Mancini, M L Vegna, G L Castoldi, et al.
Bone Marrow Transplantation|January 21, 2014
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosisM Magni, M Di Nicola, C Patti, et al.
Pageof 6